tm logo
AIMLEVIC
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 13 Jan 2020

Last Applicant/ Owned by

One Amgen Center Drive

Thousand Oaks

CA

913201799

Serial Number

87325939 filed on 06th Feb 2017

Registration Number

N/A

Correspondent Address

Timothy J. Gaul

Amgen Inc.

Trademark Operations

One Amgen Center Drive

Thousand Oaks CA 91320-1799

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

AIMLEVIC

The mark consists of two intersecting arcs with a circle at the intersection, all positioned to the left of the word "AIMLEVIC". Color is not claimed as a feature of the mark. Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraine headaches, head pain, and neurological disorders or conditions

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraine headaches, head pain, and neurological disorders or conditions

Mark Details


Serial Number

No 87325939

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.21 -

Circles that are totally or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

Description of Design Search

The mark consists of two intersecting arcs with a circle at the intersection, all positioned to the left of the word "AIMLEVIC".

Legal History


Show more

Status DateAction Taken
13th Jan 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
13th Jan 2020ABANDONMENT - NO USE STATEMENT FILED
15th Mar 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Mar 2019EXTENSION 3 FILED
13th Mar 2019TEAS EXTENSION RECEIVED
13th Mar 2019EXTENSION 3 GRANTED
07th Mar 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07th Mar 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
23rd Nov 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
21st Nov 2018EXTENSION 2 GRANTED